Your browser doesn't support javascript.
loading
Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
Kubota, Hisayoshi; Kunisawa, Kazuo; Niijima, Moe; Hirakawa, Mami; Mori, Yuko; Hasegawa, Masaya; Fujigaki, Suwako; Fujigaki, Hidetsugu; Yamamoto, Yasuko; Saito, Kuniaki; Nabeshima, Toshitaka; Mouri, Akihiro.
Afiliación
  • Kubota H; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Kunisawa K; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Niijima M; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Hirakawa M; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Mori Y; Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Hasegawa M; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Fujigaki S; Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Fujigaki H; Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Yamamoto Y; Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan.
  • Saito K; Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan; Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan; Japanese Drug Organization of Appropriate Use and Research
  • Nabeshima T; Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan; Japanese Drug Organization of Appropriate Use and Research, Aichi, Japan.
  • Mouri A; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan; Japanese Drug Organization of Appropriate Use and Research, Aichi, Japan. Electronic address: mouri@fujita-hu.ac.jp.
Biochem Biophys Res Commun ; 629: 142-151, 2022 11 12.
Article en En | MEDLINE | ID: mdl-36116377
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinurenina 3-Monooxigenasa / Quinurenina Límite: Animals Idioma: En Revista: Biochem Biophys Res Commun Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinurenina 3-Monooxigenasa / Quinurenina Límite: Animals Idioma: En Revista: Biochem Biophys Res Commun Año: 2022 Tipo del documento: Article País de afiliación: Japón